JMS Co., Ltd. AI Stock Analysis
Want to see JP:7702 full AI Analyst Report?
JMS Co., Ltd. (7702) AI Stock Analysis
JMS Co., Ltd.
(TSE/TYO:7702)
The score is held down primarily by weak financial performance—profitability has deteriorated into a recent net loss and free cash flow has been volatile and often negative—despite a relatively stable balance sheet. Technicals are a positive offset with the price above key moving averages and constructive momentum indicators. Valuation is only modestly supportive due to a negative P/E, partially balanced by a ~3.66% dividend yield.
JMS Co., Ltd. (7702) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 10.57B
- Dividend Yield
- 3.96%
- Average Volume (3M)
- 35.55K
- Price to Earnings (P/E)
- -14.9
- Beta (1Y)
- 0.59
- Revenue Growth
- -3.10%
- EPS Growth
- -645.01%
- Country
- Japan
- Employees
- 4,887
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
JMS Co., Ltd. Business Overview & Revenue Model
Company Description
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Ja...
How the Company Makes Money
null
JMS Co., Ltd. Financial Statement Overview
Summary
Financial quality is pressured by weakening profitability and cash generation. The income statement shows a return to net loss (latest year) alongside declining revenue and thinner margins, while cash flow is inconsistent with frequently negative free cash flow (including the latest year). The balance sheet is relatively stable with sizable equity, but leverage has been drifting higher, limiting flexibility if earnings remain soft.
Income Statement
34NegativeBalance Sheet
58NeutralCash Flow
38Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.43B | 65.84B | 69.75B | 65.29B | 63.74B | 58.17B |
| Gross Profit | 15.49B | 15.36B | 15.93B | 14.09B | 14.60B | 14.27B |
| EBITDA | 4.66B | 4.22B | 4.79B | 4.08B | 4.38B | 4.59B |
| Net Income | -704.00M | -784.00M | 89.00M | -36.00M | 281.00M | 826.00M |
Balance Sheet | ||||||
| Total Assets | 82.82B | 83.07B | 81.43B | 84.71B | 74.41B | 71.97B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 7.72B | 5.51B | 10.31B | 6.33B | 6.81B |
| Total Debt | 26.15B | 28.01B | 24.55B | 26.92B | 19.75B | 18.71B |
| Total Liabilities | 41.10B | 41.27B | 40.50B | 43.96B | 35.70B | 34.87B |
| Stockholders Equity | 41.66B | 41.73B | 40.84B | 40.57B | 38.53B | 36.96B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -892.00M | -1.42B | 498.00M | -1.07B | 1.14B |
| Operating Cash Flow | 0 | 1.58B | 1.47B | 3.14B | 2.48B | 4.40B |
| Investing Cash Flow | 0 | -2.25B | -3.14B | -4.24B | -3.69B | -3.68B |
| Financing Cash Flow | 0 | 2.69B | -3.19B | 4.78B | 525.00M | -499.00M |
JMS Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7702, the sentiment is Negative. The current price of 429.00 is below the 20-day moving average (MA) of 437.80, below the 50-day MA of 444.26, and below the 200-day MA of 434.41, indicating a bearish trend. The MACD of -5.00 indicates Positive momentum. The RSI at 44.15 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7702.
JMS Co., Ltd. Peers Comparison
Overall Rating
JP:454377Outperform
JP:774772Outperform
JP:773365Neutral
JP:770252Neutral
JP:808648Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 3.71T | 22.87 | 10.60% | 1.31% | 14.05% | 31.94% | |
| 72Outperform | JPY 1.02T | 31.57 | 19.88% | 1.25% | 21.16% | 156.97% | |
| 65Neutral | JPY 1.95T | 21.13 | 11.80% | 3.42% | 9.03% | -2.99% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 52Neutral | JPY 10.55B | -14.93 | ― | 3.96% | -3.10% | -645.01% | |
| 48Neutral | JPY 246.65B | 20.41 | 3.85% | 2.33% | 5.03% | -0.86% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7702 | JMS Co., Ltd. | 429.00 | 4.40 | 1.04% | |
| JP:4543 | Terumo | 2516.00 | 166.40 | 7.08% | |
| JP:7747 | Asahi Intecc Co | 3807.00 | 1457.82 | 62.06% | |
| JP:8086 | Nipro Corporation | 1331.00 | -121.91 | -8.39% | |
| JP:7733 | Olympus Corp | 1752.50 | -265.12 | -13.14% |
JMS Co., Ltd. Corporate Events
JMS Posts Narrower Losses but Lower Sales in Q1 FY2026 While Maintaining Dividend Outlook
JMS Co., Ltd. reported consolidated net sales of ¥15,128 million for the first quarter ended June 2026, a 2.7% year-on-year decline, with operating and ordinary losses narrowing slightly compared with the prior year and profit attributable to owners...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
